Europe Oncology Information System Market

Europe Oncology Information System Market Size (2024 to 2029)

The size of the Oncology Information System Market in Europe is estimated at USD 654.52 million in 2024. It is estimated to grow at a CAGR of 8.11% to reach USD 966.61 million by 2029. Growing patient populations, government-sponsored cancer control programs, and growing medical tourism trends due to low-cost treatments are major factors driving demand for cancer information systems in the European emerging countries.

The development of technologically advanced OIS, the escalating prevalence of cancer, the speedy aging population, and the escalating acquisition of oncology information systems are primarily driving the European OIS Market. It is advantageous over traditional processing and validating data, further reducing manual efforts and automating the process. Along with this, the oncology information system has excellent applicability in health care settings for better management of cancer patients. Besides, the change in healthcare policies to promote smart technologies has led to strong growth in Europe's oncology information systems market. Similarly, it improves patient care and contributes to better management of cancer patients. All these factors have led to significant growth in the oncology information systems market. With the increasing number of cancer cases, the use of these therapies increases, which drives the development of the market.

A shortage of healthcare IT professionals and high maintenance and service expenses are significant limitations hampering the market.

This research report on the Europe Oncology Information System Market has been segmented and sub-segmented into the following categories.

• By Application: Surgical Oncology, Medical Oncology, and Radiation Oncology
• By Products And Services: Patient Information Systems, Treatment Planning Systems, Consulting/Optimization Services, Implementation Services and Post-Sale and Maintenance Services
• By End Users: Hospitals & Physician’s Offices, Research Centres and Government Institutions
• By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe

Geographically, Europe has the second-largest market for the oncology information system in the world by share. Factors such as the growing incidence of cancer and a rapidly aging population are expected to drive the region's market growth.

Europe dominates the global oncology information systems market due to its high penetration and well-established healthcare systems. Besides, they are expected to remain dominant throughout the forecast period.

The German oncology information systems market is estimated to grow at a CAGR of 7.6% during the forecast period to reach nearly USD 240 million in 2029 from USD 160 million in 2024. Germany is a European economy leader that significantly influences cancer information in the Europe Oncology Information systems market. Well-developed healthcare infrastructure and the increased penetration of digitization and the high prevalence of cancer in the country are expected to increase the size of the country's oncology information systems market. It is mostly due to the increase in the geriatric population, so the risk associated with many types of cancer is expected to increase dramatically in the years to come. Besides, the presence of highly specialized urologists for cancer treatment and a more achievable cost compared to the UK, which attracts medical tourism to the country, are also expected to create market growth opportunities in the near future. 

Key players operating in the Europe Oncology Information System Market profiled in this report are Accuray Incorporated (U.S.), Altos Solutions, Inc. (U.S.), Cerner Corporation (U.S.), Elekta AB (Sweden), Epic Systems Corporation (U.S.), Koninklijke Philips N.V. (The Netherlands), McKesson Corporation (U.S.), and Varian Medical Systems, Inc. (U.S.).